Abstract:Abstract Background Hydrogenobyrinic acid is a key intermediate of the de-novo aerobic biosynthesis pathway of vitamin B 12 . The introduction of a heterologous de novo vitamin B 12 biosynthesis pathway in Escherichia coli offers an alternative approach for its production. Although E. coli avoids major limitations that currently faced by industrial producers of vitamin B 12 , such as long growth cycles, the insufficient supply of hydrogenobyrinic acid restricts industrial vitamin B 12 production. Results By designing combinatorial ribosomal binding site libraries of the hemABCD genes in vivo, we found that their optimal relative translational initiation rates are 10:1:1:5. The transcriptional coordination of the uroporphyrinogen III biosynthetic module was realized by promoter engineering of the hemABCD operon. Knockdown of competitive heme and siroheme biosynthesis pathways by RBS engineering enhanced the hydrogenobyrinic acid titer to 20.54 and 15.85 mg L −1 , respectively. Combined fine-tuning of the heme and siroheme biosynthetic pathways enhanced the hydrogenobyrinic acid titer to 22.57 mg L −1 , representing a remarkable increase of 1356.13% compared with the original strain FH215-HBA. Conclusions Through multi-level metabolic engineering strategies, we achieved the metabolic balance of the uroporphyrinogen III biosynthesis pathway, eliminated toxicity due to by-product accumulation, and finally achieved a high HBA titer of 22.57 mg L −1 in E. coli . This lays the foundation for high-yield production of vitamin B 12 in E. coli and will hopefully accelerate its industrial production.

Heme biosensor-guided in vivo pathway optimization and directed evolution for efficient biosynthesis of heme

Tuning the Binding Affinity of Heme-Responsive Biosensor for Precise and Dynamic Pathway Regulation

Development of a growth-coupled selection platform for directed evolution of heme biosynthetic enzymes in Corynebacterium glutamicum

Biosynthesis, acquisition, regulation, and upcycling of heme: recent advances

Multi-modular metabolic engineering of heme synthesis in Corynebacterium glutamicum

Recent advances in microbial synthesis of free heme

Microbial Synthesis of Heme B: Biosynthetic Pathways, Current Strategies, Detection, and Future Prospects

Developing a novel heme biosensor to produce high-active hemoproteins in Pichia pastoris through comparative transcriptomics

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Enhanced Production of High-Value Porphyrin Compound Heme by Metabolic Engineering Modification and Mixotrophic Cultivation of Synechocystis sp. PCC6803

Improved biosynthesis of heme in Bacillus subtilis through metabolic engineering assisted fed-batch fermentation

Combinatorial Optimization of MEP Pathway to Improve β-Carotene Yield

Multidimensional engineering of Saccharomyces cerevisiae for the efficient production of heme by exploring the cytotoxicity and tolerance of heme

Improved production of heme using metabolically engineered Escherichia coli

Enhanced Production of Coenzyme Q(10) by Self-Regulating the Engineered Mep Pathway in Rhodobacter Sphaeroides

Optimization of hydrogenobyrinic acid biosynthesis in Escherichia coli using multi-level metabolic engineering strategies

Efficient heterologous expression of cytochrome P450 enzymes in microorganisms for the biosynthesis of natural products

Engineering Escherichia coli for efficient assembly of heme proteins

Regulation of the Heme Biosynthetic Pathway for Combinational Biosynthesis of Phycocyanobilin in Escherichia Coli

Synergistic Improvement of 5-Aminolevulinic Acid Production with Synthetic Scaffolds and System Pathway Engineering

Designing artificial pathways for improving chemical production